{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:44:05Z","timestamp":1794588245001,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["348-2013-6609"],"award-info":[{"award-number":["348-2013-6609"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010058","name":"Stiftelsen L\u00e4kare mot AIDS Forskningsfond","doi-asserted-by":"crossref","award":["Fob2016-0008"],"award-info":[{"award-number":["Fob2016-0008"]}],"id":[{"id":"10.13039\/501100010058","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Research Foundation (NRF) in South Africa","award":["UID 70878"],"award-info":[{"award-number":["UID 70878"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      To reduce acquisition and relapse of bacterial vaginosis (BV), lactobacilli must be maintained in the vaginal microbiome. Probiotic lactobacilli may aid this purpose. We investigated whether vaginal probiotics (containing\n                      <jats:italic>Lactobacillus rhamnosus<\/jats:italic>\n                      DSM 14870 and\n                      <jats:italic>Lactobacillus gasseri<\/jats:italic>\n                      DSM 14869) would result in vaginal colonisation with lactobacilli in women with and without BV.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective, partially randomised, exploratory pilot study was conducted in Soweto, South Africa. Thirty-nine sexually-active, HIV negative women were enrolled from October 2014 to May 2016 into three arms. Women who did not have BV (Group 1,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913) self-administered probiotic capsules vaginally once daily for 30\u2009days, then once a week until Day 190. Women diagnosed with BV were randomized into Group 2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) or Group 3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914) and treated with the triple oral antibiotic combination for vaginal discharge syndrome per South African guidelines (cefixime 400\u2009mg stat, doxycycline 100\u2009mg BD for 7\u2009days and metronidazole 2\u2009g stat). Immediately after antibiotic treatment, women in Group 2 self-administered probiotic capsules vaginally once daily for 30\u2009days then vaginally once a week until Day 190. Women in Group 3 were not given lactobacilli.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the study,\n                      <jats:italic>L. rhamnosus<\/jats:italic>\n                      DSM 14870 or\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      DSM 14869, were isolated in 5\/13 (38.5%) women in Group 1 compared to 10\/12 (83.3%) women in Group 2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.041). The 1-month and 6-month BV cure rates were similar (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u2009\u00a00.05) between Group 2 (42 and 25%) compared to Group 3 (36 and 25%). In Group 2, no correlation was observed between the frequency of isolation of the two\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      strains and the 1-month or 6-month cure rate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Supplementation with vaginal probiotic capsules resulted in colonisation of the vagina by the\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      strains (\n                      <jats:italic>L. rhamnosus<\/jats:italic>\n                      DSM 14870 and\n                      <jats:italic>L. gasseri<\/jats:italic>\n                      DSM 14869) contained in the capsules. We observed low initial cure rates of BV after a stat dose of metronidazole and that the probiotic did not improve BV cure rates or alleviate recurrence which could be due to treatment failure or very limited power of the study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Registered at the Pan African Clinical Trial Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pactr.org\">www.pactr.org<\/jats:ext-link>\n                      ) on April 13, 2018 (retrospectively registered). Trial identification number: PACTR201804003327269.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-019-4425-1","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T10:07:31Z","timestamp":1568801251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-349X","authenticated-orcid":false,"given":"Harold","family":"Marcotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per G\u00f6ran","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper Krogh","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse Sommer","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Brandsborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Laher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Otwombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"4425_CR1","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa043802","volume":"353","author":"DN Fredricks","year":"2005","unstructured":"Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353:1899\u2013911.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"4425_CR2","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4680\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4425_CR3","doi-asserted-by":"publisher","first-page":"e1001251","DOI":"10.1371\/journal.pmed.1001251","volume":"9","author":"CR Cohen","year":"2012","unstructured":"Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, Donnell D, Celum C, Kapiga S, Delany S, Bukusi EA. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012;9:e1001251.","journal-title":"PLoS Med"},{"key":"4425_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2016.12.013","volume":"46","author":"C Gosmann","year":"2017","unstructured":"Gosmann C, Anahtar MN, Handley SA, Farcasanu M, Abu-Ali G, Bowman BA, Padavattan N, Desai C, Droit L, Moodley A, et al. Lactobacillus-deficient Cervicovaginal bacterial communities are associated with increased HIV Acquisition in Young South African Women. Immunity. 2017;46:29\u201337.","journal-title":"Immunity."},{"key":"4425_CR5","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/587491","volume":"197","author":"LY Shin","year":"2008","unstructured":"Shin LY, Kaul R. Stay it with flora: maintaining vaginal health as a possible avenue for prevention of human immunodeficiency virus acquisition. J Infect Dis. 2008;197:1355\u20137.","journal-title":"J Infect Dis"},{"key":"4425_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14\u201322.","journal-title":"Am J Med"},{"key":"4425_CR7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297\u2013301.","journal-title":"J Clin Microbiol"},{"key":"4425_CR8","unstructured":"Prevention CfDCa. Sexually Transmitted Diseases Treatment Guidelines. In:  Morbidity and Mortality Weekly Report, vol. 6. p. 1\u20131372015. 1\u2013137."},{"key":"4425_CR9","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006;193:1478\u201386.","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"4425_CR10","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1086\/514725","volume":"28","author":"MR Joesoef","year":"1999","unstructured":"Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis. 1999;28(Suppl 1):S57\u201365.","journal-title":"Clin Infect Dis"},{"key":"4425_CR11","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1086\/462427","volume":"192","author":"L Myer","year":"2005","unstructured":"Myer L, Denny L, Telerant R, Souza M, Wright TC Jr, Kuhn L. Bacterial vaginosis and susceptibility to HIV infection in south African women: a nested case-control study. J Infect Dis. 2005;192:1372\u201380.","journal-title":"J Infect Dis"},{"key":"4425_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/sextrans-2015-052160","volume":"92","author":"SC Francis","year":"2016","unstructured":"Francis SC, Looker C, Vandepitte J, Bukenya J, Mayanja Y, Nakubulwa S, Hughes P, Hayes RJ, Weiss HA, Grosskurth H. Bacterial vaginosis among women at high risk for HIV in Uganda: high rate of recurrent diagnosis despite treatment. Sex Transm Infect. 2016;92:142\u20138.","journal-title":"Sex Transm Infect"},{"key":"4425_CR13","doi-asserted-by":"publisher","first-page":"e1002511","DOI":"10.1371\/journal.pmed.1002511","volume":"15","author":"EA Torrone","year":"2018","unstructured":"Torrone EA, Morrison CS, Chen PL, Kwok C, Francis SC, Hayes RJ, Looker KJ, McCormack S, McGrath N, van de Wijgert J, et al. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: an individual participant data meta-analysis of 18 HIV prevention studies. PLoS Med. 2018;15:e1002511.","journal-title":"PLoS Med"},{"key":"4425_CR14","first-page":"2004","volume-title":"Guidelines for the Management of Sexually Transmitted Infections","author":"Organisation WH","year":"2004","unstructured":"Organisation WH. Guidelines for the Management of Sexually Transmitted Infections; 2004. p. 2004."},{"key":"4425_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/10158782.2009.11441341","volume":"24","author":"DA Lewis","year":"2015","unstructured":"Lewis DA, Maruma E. Revision of the national guideline for first-line comprehensive management and control of sexually transmitted infections: what's new and why? Southern African Journal of Epidemiology and Infection. 2015;24:6\u20139.","journal-title":"Southern African Journal of Epidemiology and Infection"},{"key":"4425_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/infdis\/jis298","volume":"206","author":"K Mlisana","year":"2012","unstructured":"Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, Passmore JA, Grobler AC, Sturm AW, Williamson C, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206:6\u201314.","journal-title":"J Infect Dis"},{"key":"4425_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2180-12-83","volume":"12","author":"V Jespers","year":"2012","unstructured":"Jespers V, Menten J, Smet H, Poradosu S, Abdellati S, Verhelst R, Hardy L, Buve A, Crucitti T. Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests. BMC Microbiol. 2012;12:83.","journal-title":"BMC Microbiol"},{"key":"4425_CR18","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1128\/JCM.40.8.2746-2749.2002","volume":"40","author":"A Vasquez","year":"2002","unstructured":"Vasquez A, Jakobsson T, Ahrne S, Forsum U, Molin G. Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol. 2002;40:2746\u20139.","journal-title":"J Clin Microbiol"},{"key":"4425_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12941-016-0132-6","volume":"15","author":"Z Woodman","year":"2016","unstructured":"Woodman Z. Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa. Ann Clin Microbiol Antimicrob. 2016;15:16.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"4425_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2334-13-43","volume":"13","author":"S Pendharkar","year":"2013","unstructured":"Pendharkar S, Magopane T, Larsson PG, de Bruyn G, Gray GE, Hammarstrom L, Marcotte H. Identification and characterisation of vaginal lactobacilli from south African women. BMC Infect Dis. 2013;13:43.","journal-title":"BMC Infect Dis"},{"key":"4425_CR21","doi-asserted-by":"publisher","first-page":"11974","DOI":"10.1038\/s41598-017-12198-6","volume":"7","author":"V Jespers","year":"2017","unstructured":"Jespers V, Kyongo J, Joseph S, Hardy L, Cools P, Crucitti T, Mwaura M, Ndayisaba G, Delany-Moretlwe S, Buyze J, et al. A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa. Sci Rep. 2017;7:11974.","journal-title":"Sci Rep"},{"key":"4425_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12879-015-0825-z","volume":"15","author":"V Jespers","year":"2015","unstructured":"Jespers V, van de Wijgert J, Cools P, Verhelst R, Verstraelen H, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, Mandaliya K, Menten J, et al. The significance of Lactobacillus crispatus and L vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women. BMC Infect Dis. 2015;15:115.","journal-title":"BMC Infect Dis"},{"key":"4425_CR23","doi-asserted-by":"publisher","first-page":"e0201003","DOI":"10.1371\/journal.pone.0201003","volume":"13","author":"T Crucitti","year":"2018","unstructured":"Crucitti T, Hardy L, van de Wijgert J, Agaba S, Buyze J, Kestelyn E, Delvaux T, Mwambarangwe L, De Baetselier I, Jespers V. Ring plus study g. contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: a randomised, open-label longitudinal study in Rwandan women. PLoS One. 2018;13:e0201003.","journal-title":"PLoS One"},{"key":"4425_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12879-015-0831-1","volume":"15","author":"R Gautam","year":"2015","unstructured":"Gautam R, Borgdorff H, Jespers V, Francis SC, Verhelst R, Mwaura M, Delany-Moretlwe S, Ndayisaba G, Kyongo JK, Hardy L, et al. Correlates of the molecular vaginal microbiota composition of African women. BMC Infect Dis. 2015;15:86.","journal-title":"BMC Infect Dis"},{"key":"4425_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","volume":"42","author":"MN Anahtar","year":"2015","unstructured":"Anahtar MN, Byrne EH, Doherty KE, Bowman BA, Yamamoto HS, Soumillon M, Padavattan N, Ismail N, Moodley A, Sabatini ME, et al. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity. 2015;42:965\u201376.","journal-title":"Immunity."},{"key":"4425_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1471-2334-11-223","volume":"11","author":"PG Larsson","year":"2011","unstructured":"Larsson PG, Brandsborg E, Forsum U, Pendharkar S, Andersen KK, Nasic S, Hammarstrom L, Marcotte H. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC Infect Dis. 2011;11:223.","journal-title":"BMC Infect Dis"},{"key":"4425_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6874-8-3","volume":"8","author":"PG Larsson","year":"2008","unstructured":"Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health. 2008;8:3.","journal-title":"BMC Womens Health"},{"key":"4425_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12879-015-0971-3","volume":"15","author":"S Pendharkar","year":"2015","unstructured":"Pendharkar S, Brandsborg E, Hammarstrom L, Marcotte H, Larsson PG. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection. BMC Infect Dis. 2015;15:255.","journal-title":"BMC Infect Dis"},{"key":"4425_CR29","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.micinf.2006.01.003","volume":"8","author":"K Anukam","year":"2006","unstructured":"Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, Reid G. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006;8:1450\u20134.","journal-title":"Microbes Infect"},{"key":"4425_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijgo.2010.07.008","volume":"111","author":"R Hummelen","year":"2010","unstructured":"Hummelen R, Changalucha J, Butamanya NL, Cook A, Habbema JD, Reid G. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J Gynaecol Obstet. 2010;111:245\u20138.","journal-title":"Int J Gynaecol Obstet"},{"key":"4425_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/mi.2011.30","volume":"4","author":"LA Lagenaur","year":"2011","unstructured":"Lagenaur LA, Sanders-Beer BE, Brichacek B, Pal R, Liu X, Liu Y, Yu R, Venzon D, Lee PP, Hamer DH. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol. 2011;4:648\u201357.","journal-title":"Mucosal Immunol"},{"key":"4425_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/sti.78.6.413","volume":"78","author":"CA Ison","year":"2002","unstructured":"Ison CA, Hay PE. Validation of a simplified grading of gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect. 2002;78:413\u20135.","journal-title":"Sex Transm Infect"},{"key":"4425_CR33","unstructured":"Larsson PG, Breding K, Vikstom I, Larsson J. Validation of Hay\/Ison criteria for a diagnosis of bacterial vaginosis using an air-dried wet smear. Jacobs Journal of Gynecology and Obstetrics. 2018;5(3):042."},{"key":"4425_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0167-7012(02)00018-0","volume":"50","author":"AL McOrist","year":"2002","unstructured":"McOrist AL, Jackson M, Bird AR. A comparison of five methods for extraction of bacterial DNA from human faecal samples. J Microbiol Methods. 2002;50:131\u20139.","journal-title":"J Microbiol Methods"},{"key":"4425_CR35","first-page":"50","volume":"6","author":"MH Bibalan","year":"2017","unstructured":"Bibalan MH, Eshaghi M, Rohani M, Pourshafie MR, Talebi M. Determination of Bacteriocin genes and antibacterial activity of Lactobacillus strains isolated from fecal of healthy individuals. Int J Mol Cell Med. 2017;6:50\u20135.","journal-title":"Int J Mol Cell Med"},{"key":"4425_CR36","doi-asserted-by":"publisher","first-page":"e0144467","DOI":"10.1371\/journal.pone.0144467","volume":"10","author":"M Rohani","year":"2015","unstructured":"Rohani M, Noohi N, Talebi M, Katouli M, Pourshafie MR. Highly heterogeneous probiotic Lactobacillus species in healthy Iranians with low functional activities. PLoS One. 2015;10:e0144467.","journal-title":"PLoS One"},{"key":"4425_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/dc.20793","volume":"36","author":"JM Klomp","year":"2008","unstructured":"Klomp JM, Verbruggen BS, Korporaal H, Boon ME, de Jong P, Kramer GC, van Haaften M, Heintz AP. Gardnerella vaginalis and Lactobacillus sp in liquid-based cervical samples in healthy and disturbed vaginal flora using cultivation-independent methods. Diagn Cytopathol. 2008;36:277\u201384.","journal-title":"Diagn Cytopathol"},{"key":"4425_CR38","first-page":"126","volume":"8","author":"F Di Cello","year":"1996","unstructured":"Di Cello F, Fani R. A molecular strategy for the study of natural bacterial communities by PCR-based techniques. Minerva Biotecnologica. 1996;8:126\u201334.","journal-title":"Minerva Biotecnologica"},{"key":"4425_CR39","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/S0723-2020(00)80024-7","volume":"23","author":"M Ventura","year":"2000","unstructured":"Ventura M, Casas IA, Morelli L, Callegari ML. Rapid amplified ribosomal DNA restriction analysis (ARDRA) identification of Lactobacillus spp. isolated from fecal and vaginal samples. Syst Appl Microbiol. 2000;23:504\u20139.","journal-title":"Syst Appl Microbiol"},{"key":"4425_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.micres.2017.08.003","volume":"205","author":"H Marcotte","year":"2017","unstructured":"Marcotte H, Krogh Andersen K, Lin Y, Zuo F, Zeng Z, Larsson PG, Brandsborg E, Bronstad G, Hammarstrom L. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag((R)) probiotic vaginal capsules. Microbiol Res. 2017;205:88\u201398.","journal-title":"Microbiol Res"},{"key":"4425_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2529336","volume":"32","author":"RR Hocking","year":"1976","unstructured":"Hocking RR. Analysis and selection of variables in linear-regression. Biometrics. 1976;32:1\u201349.","journal-title":"Biometrics."},{"key":"4425_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109670","volume":"9","author":"V Jespers","year":"2014","unstructured":"Jespers V, Crucitti T, Menten J, Verhelst R, Mwaura M, Mandaliya K, Ndayisaba GF, Delany-Moretlwe S, Verstraelen H, Hardy L, et al. Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study. PLoS One. 2014;9:e109670.","journal-title":"PLoS One"},{"key":"4425_CR43","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jama.1985.03360080058029","volume":"254","author":"J Swedberg","year":"1985","unstructured":"Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA. 1985;254:1046\u20139.","journal-title":"JAMA."},{"key":"4425_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/0956462417740487","volume":"29","author":"SL Barnabas","year":"2018","unstructured":"Barnabas SL, Dabee S, Passmore JS, Jaspan HB, Lewis DA, Jaumdally SZ, Gamieldien H, Masson L, Muller E, Maseko VD, et al. Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV. Int J STD AIDS. 2018;29:531\u20139.","journal-title":"Int J STD AIDS"},{"key":"4425_CR45","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1086\/592974","volume":"47","author":"KA Fethers","year":"2008","unstructured":"Fethers KA, Fairley CK, Hocking JS, Gurrin LC, Bradshaw CS. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis. 2008;47:1426\u201335.","journal-title":"Clin Infect Dis"},{"key":"4425_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/COH.0000000000000431","volume":"13","author":"SS Abdool Karim","year":"2018","unstructured":"Abdool Karim SS, Passmore JS, Baxter C. The microbiome and HIV prevention strategies in women. Curr Opin HIV AIDS. 2018;13:81\u20137.","journal-title":"Curr Opin HIV AIDS"},{"key":"4425_CR47","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.aai9383","volume":"356","author":"NR Klatt","year":"2017","unstructured":"Klatt NR, Cheu R, Birse K, Zevin AS, Perner M, Noel-Romas L, Grobler A, Westmacott G, Xie IY, Butler J, et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 2017;356:938\u201345.","journal-title":"Science."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4425-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4425-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4425-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T08:13:45Z","timestamp":1600330425000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4425-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4425"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4425-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Review Board of the University of the Witwatersrand Human Research Ethics Committee (Medical) approved the study. Written informed consent was collected from all patients enrolled. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EB and LSM are respectively Chief Scientific Officer and Research specialist at the company Bifodan A\/S, Denmark which develop and commercialise probiotic products. The company has had no influence on study design and data interpretation of the article. The other authors declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"824"}}